Patents by Inventor Taeun Park

Taeun Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10936086
    Abstract: A system for inputting information by utilizing an extension key.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: March 2, 2021
    Assignee: TP-I CO., LTD.
    Inventors: Taeun Park, Sangjung Shim, Hee-Myong Ro, Eun-soo Park, Minsub Shim
  • Patent number: 10664064
    Abstract: The present invention brings the easiness in the input of non-vocabulary phrase and sentence by applying the disambiguation input method used as a predictive input method for words in English-speaking countries to non-vocabulary phrases and sentences including not only characters but also ‘space’ and symbols.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: May 26, 2020
    Inventors: Taeun Park, Sangjung Shim
  • Publication number: 20180329513
    Abstract: The present invention brings the easiness in the input of non-vocabulary phrase and sentence by applying the disambiguation input method used as a predictive input method for words in English-speaking countries to non-vocabulary phrases and sentences including not only characters but also ‘space’ and symbols.
    Type: Application
    Filed: May 9, 2018
    Publication date: November 15, 2018
    Inventors: Taeun Park, Sangjung Shim
  • Patent number: 9017719
    Abstract: Provided is an injectable drug carrier including a non-toxic Layered Double Hydroxide (LDH) and pharmaceutically acceptable excipients. Provided is also a method of preparing the injectable drug carrier, the method including: synthesizing LDH with various compositions and controlling the size and shape of the LDH at a level that the LDH has no adverse effect in vivo. A solution obtained by dispersing the LDH in a solvent is injected in vivo. According to the method, nano-size LDH that does not affect a blood vessel in vivo can be synthesized. The LDH thus synthesized has no adverse effect in vivo even at a concentration of 400 mg/kg, and thus can contribute to establishment of a drug delivery system capable of improving the delivery efficiency of a specific drug.
    Type: Grant
    Filed: July 3, 2012
    Date of Patent: April 28, 2015
    Assignee: Nanohybrid Co., Ltd.
    Inventors: Taeun Park, Jin-Ho Choy, Jae-Min Oh, Ji-Sun Jung
  • Publication number: 20140375569
    Abstract: A system for inputting information by utilizing an extension key.
    Type: Application
    Filed: March 13, 2014
    Publication date: December 25, 2014
    Applicant: TP-I CO., LTD.
    Inventors: Taeun Park, Sangjung Shim, Hee-Myong Ro, Eun-soo Park, Minsub Shim
  • Publication number: 20130174091
    Abstract: A Chinese input method in a mobile device comprising a touch screen, the method comprise classifying a plurality of initial icons into initial icon groups according to a predetermined criteria and arranging the initial icon groups on a virtual keyboard of the touch screen to display an initial icon keyboard, determining one or more of the plurality of the initial icons as initial icon input based on touch input on the initial icon keyboard, arranging a plurality of final icons on the virtual keyboard of the touch screen to display a final icon keyboard and determining one or more of the plurality of the final icons as final icon input based on touch input on the final icon keyboard.
    Type: Application
    Filed: August 23, 2012
    Publication date: July 4, 2013
    Inventors: Taeun PARK, Sangjung SHIM, Eun-soo PARK
  • Publication number: 20120276170
    Abstract: Provided is an injectable drug carrier including a non-toxic Layered Double Hydroxide (LDH) and pharmaceutically acceptable excipients. Provided is also a method of preparing the injectable drug carrier, the method including: synthesizing LDH with various compositions and controlling the size and shape of the LDH at a level that the LDH has no adverse effect in vivo. A solution obtained by dispersing the LDH in a solvent is injected in vivo. According to the method, nano-size LDH that does not affect a blood vessel in vivo can be synthesized. The LDH thus synthesized has no adverse effect in vivo even at a concentration of 400 mg/kg, and thus can contribute to establishment of a drug delivery system capable of improving the delivery efficiency of a specific drug.
    Type: Application
    Filed: July 3, 2012
    Publication date: November 1, 2012
    Applicant: NANOHYBRID CO., LTD.
    Inventors: Taeun PARK, Jin-Ho CHOY, Jae-Min OH, Ji-Sun JUNG
  • Publication number: 20120149477
    Abstract: The present invention relates to an information input system and method using an extension key. The information input system comprises: an input unit including a plurality of divided regions, for detecting a user selected divided region among the plurality of divided regions; and an input analysis unit for allocating corresponding information to the plurality of divided regions, and analyzing, if the input unit detects a user selected divided region among the plurality of divided regions, whether or not information allocated to the divided region is input. The input analysis unit allocates an extension key to at least one divided region out of the plurality of divided regions; and once the extension key is selected, the input analysis unit allocates new information to an extended region which is a divided region determined according to the extension key.
    Type: Application
    Filed: August 23, 2010
    Publication date: June 14, 2012
    Inventors: Taeun Park, Sangjung Shim, Hee-Myong Ro, Eun-Soo Park, Minsub Shim
  • Publication number: 20100103127
    Abstract: A virtual keyboard input system using a pointing device in a digital device. The virtual keyboard input system includes: a sensor unit sensing a contact and a two-dimensional contact position; a switch unit; and a control unit dividing a contact sensitive region of the sensor unit into multiple division regions according to XY coordinates, assigning virtual keys of a virtual keyboard to the division regions, and when the switch unit is turned on, controlling an input of information for a virtual key assigned to a division region which is contacted among the division regions.
    Type: Application
    Filed: August 24, 2009
    Publication date: April 29, 2010
    Inventors: Taeun Park, Sangjung Shim
  • Publication number: 20100047307
    Abstract: Provided is an injectable drug carrier including a non-toxic Layered Double Hydroxide (LDH) and pharmaceutically acceptable excipients. Provided is also a method of preparing the injectable drug carrier, the method including: synthesizing LDH with various compositions and controlling the size and shape of the LDH at a level that the LDH has no adverse effect in vivo. A solution obtained by dispersing the LDH in a solvent is injected in vivo. According to the method, nano-size LDH that does not affect a blood vessel in vivo can be synthesized. The LDH thus synthesized has no adverse effect in vivo even at a concentration of 400 mg/kg, and thus can contribute to establishment of a drug delivery system capable of improving the delivery efficiency of a specific drug.
    Type: Application
    Filed: June 3, 2005
    Publication date: February 25, 2010
    Applicant: NANOHYBRID CO., LTD.
    Inventors: Taeun Park, Jin-ho Choy, Jae-Min Oh, Ji-Sun Jung
  • Publication number: 20080153907
    Abstract: Provided is a pharmaceutical composition for the treatment of liver cancer, including a layered metal hydroxide-retinoic acid (LMH-RA) hybrid as a novel drug delivery system which shows few side effects of retinoic acid, good drug stability, sustained drug release, and improved drug delivery efficiency.
    Type: Application
    Filed: February 22, 2006
    Publication date: June 26, 2008
    Applicant: NANOHYBRID CO., LTD.
    Inventors: Jin-ho Choy, Taeun Park, Sang-tae Kim, You-hwan Son
  • Publication number: 20080119519
    Abstract: Provided are a hybrid of a poorly soluble basic drug and a layered silicate, including a water-soluble basic polymer, and a method of preparing the same. The water-soluble basic polymer may be an aminoalkylmethacrylate copolymer (e.g., Eudragit E 100: a copolymer composed of 1:2:1 ratio of butyl methacrylate, (2,2-dimethylaminoethyl)methacrylate, and methyl methacrylate, Degussa) or polyvinylacetal diethylaminoacetate (AEA). In an oral formulation including the hybrid, a short-term dissolution of the poorly soluble drug can be increased to 90%, thereby increasing drug bioavailability.
    Type: Application
    Filed: February 21, 2006
    Publication date: May 22, 2008
    Applicant: NANOHYBRID CO., LTD.
    Inventors: Jin-Ho Choy, Taeun Park, Yoon-joo Lee, Dong-Youn Kim, Jin-Kuen Park
  • Publication number: 20060013877
    Abstract: The present invention provides the hybrids wherein itraconazole, cyclosporine or carvedilol are intercalated into the interlayers and/or absorbed onto the surfaces of layered silicates. The hybrids according to the present invention enable the maximization of bioavailability of drugs by dissolving the drugs from the layered silicates. Furthermore, the present invention provides the preparing methods of the hybrids.
    Type: Application
    Filed: July 22, 2003
    Publication date: January 19, 2006
    Applicant: Nanohybrid Co., Ltd.
    Inventors: Taeun Park, Hyun Jung, Hyun Kim, Jin Choy, Chi Lee